Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin

Introduction: Hepatitis C virus (HCV) infections remain an increasingly prevalent and emergent health problem worldwide, causing a wide spectrum of liver diseases. Combination therapy with pegylated interferon (PEG-IFN) of peginterferon alfa-2a and oral ribavirinis currently recognized as the standa...

Full description

Bibliographic Details
Main Authors: Sadeq, Refat, Mohtady, Heba, Al Badawy, Nissreen, Ibrahim, Salwa, Omar, Abdul Rahman, Husseiny, Mohamed I., El Zowalaty, Mohamed
Format: Article
Language:English
English
Published: Open Learning on Enteric Pathogens 2013
Online Access:http://psasir.upm.edu.my/id/eprint/29898/1/Endogenous%20IFN%CE%B3%20in%20chronic%20HCV%20genotype%204%20patients%20treated%20with%20PEG.pdf

Internet

http://psasir.upm.edu.my/id/eprint/29898/1/Endogenous%20IFN%CE%B3%20in%20chronic%20HCV%20genotype%204%20patients%20treated%20with%20PEG.pdf

Similar Items